Mahesh Paramar, Ph.D., from the Medical Research Council Clinical Trials Unit in London, along with some colleagues have "modified standard clinical trial methodology so that multiple therapies or combinations can be compared in a single trial." What this means, is that Phase II and Phase III goals are combined into a single "multi-phase trial," that also would have the benefit of needing less patients. As stated in this article, from Science Daily, Parmar and his colleagues wrote an article for the Journal of the National Cancer Institute detailing their proposal. regarding the practicality of using the approach outlined by Paramer, the authors of the proposal wrote:
"With three real examples, we hope that we have shown that such trials are feasible and can lead to major improvements in speed and decision making"
Monday, September 8, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment